Polar Asset Management Partners’s Citius Oncology CTOR Stock Holding History

Polar Asset Management Partners’s Portfolio CTOR Stock Details CTOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-200,000	Closed	-$2.21M	–	857
2024 Q1	$2.21M	Sell	200,000 -200,000	-50%	-$2.2M	0.04%	348
2023 Q4	$4.38M	Hold	400,000	–	–	0.08%	243
2023 Q3	$4.31M	Hold	400,000	–	–	0.1%	252
2023 Q2	$4.21M	Hold	400,000	–	–	0.08%	327
2023 Q1	$4.14M	Hold	400,000	–	–	0.06%	383
2022 Q4	$4.06M	Buy	+400,000	New	+$4.06M	0.05%	486

Other funds holding CTOR

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

MSU

Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

LSC

Logan Stone Capital Chicago, Illinois $360M AUM 9.71% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Polar Asset Management Partners's CTOR Position: Q2 2024 in Review

Polar Asset Management Partners sold out of Citius Oncology (CTOR) in Q2 2024, closing a stake of 200,000 shares — an estimated $2.21M sold.

Polar Asset Management Partners first reported a position in CTOR in Q4 2022 and held it in 6 quarters. The position peaked at $4.38M in Q4 2023. 13 funds tracked by Wall St. Rank hold CTOR as of Q2 2024.

Polar Asset Management Partners reported no remaining Citius Oncology position as of Q2 2024 after selling out during the quarter.
Polar Asset Management Partners sold 200,000 Citius Oncology shares in Q2 2024, an estimated $2.21M.
Polar Asset Management Partners first reported a position in Citius Oncology in Q4 2022 and held it in 6 quarters.
Polar Asset Management Partners's Citius Oncology position peaked at $4.38M in Q4 2023.
13 funds tracked by Wall St. Rank held Citius Oncology as of Q2 2024.

Based on Polar Asset Management Partners's 13F filing for Q2 2024, filed 14 Aug 2024.